Organizational predictors of pharmacological innovation adoption: The case of disulfiram

Journal of Drug Issues

Volumn 35, Issue 3, 2005, Pages 559-574

  Knudsen, Hannah K ^a   Roman, Paul M ^a   Ducharme, Lori J ^b   Johnson, J Aaron ^c  

^a UNIVERSITY OF GEORGIA   (United States)

^b UNIVERSITY OF GEORGIA   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

DISULFIRAM;

ACADEMIC ACHIEVEMENT; ALCOHOLISM; CLINICAL PRACTICE; CONFERENCE PAPER; COUNSELING; DRUG DEPENDENCE TREATMENT; GROUP THERAPY; HEALTH CARE UTILIZATION; HUMAN; LOGISTIC REGRESSION ANALYSIS; MEDICAL RESEARCH; PHILOSOPHY; PREDICTION; PROFESSIONAL PRACTICE; RELIGION; WORKER;

EID: 25844495789     PISSN: 00220426     EISSN: None     Source Type: Journal    
DOI: 10.1177/002204260503500308     Document Type: Conference Paper

References (40)

1. Anton, R. F. 2001 Pharmacologic approaches to management of alcoholism. Journal of Clinical Psychiatry, 62(Suppl 20), 11-17.
2. Banys, P. 1988 The clinical use of disulfiram (Antabuse): A review. Journal of Psychoactive Drugs, 20, 243-260.
3. Brewer, C., Meyers, R. J., & Johnsen, J. 2000 Does disulfiram help to prevent relapse in alcohol abuse? CNS Drugs, 15, 329-341.
4. Carroll, K. M., Nich, C., Ball, S. A., McCance, E., Frankfurter, T. L., & Rounsaville, B.J. 2000 One-year follow-up of disulfiram and psychotherapy for cocaine-alcohol users: Sustained effects of treatment. Addiction, 95, 1335-1349.
5. Carroll, K. M., Nich, C., Ball, S. A., McCance, E., & Rounsaville, B. J. 1998 Treatment of cocaine and alcohol dependence with psychotherapy and disulfiram. Addiction, 93, 713-728.
6. Chandrasekaran, R., Sivaprakash, B., & Chitraleka, V. 2001 Five years of alcohol de-addiction services in a tertiary care general hospital. Indian Journal of Psychiatry, 43, 58-60.
7. Chick, J., Gough, K., Falkowski, W., Kershaw, P., Hore, B., Ritson, B., Ropner, R., & Torley, D. 1992 Disulfiram treatment for alcoholism. British Journal of Psychiatry, 161, 84-89.
8. Damanpour, F. 1991 Organizational innovation: A meta-analysis of effects of determinants and moderators. Academy of Management Journal, 34, 555-590.
9. Fichman, R. G. 2001 The role of aggregation in the measurement of IT-related organizational innovation. MS Quarterly, 25, 427-455.
10. Fuller, R. K., Branchey, L., Brightwell, D. R., Derman, R. M., Emrick, C. D., Iber, F. L., James, K. E., Lacoursiere, R. B., Lee, K. K., & Lowenstam, I. 1986 Disulfiram treatment of alcoholism: A Veteran's Administration cooperative study. Journal of the American Medical Association, 256, 1449-1455.
11. Garbutt, J. C., West, S. L., Carey, T. S., Lohr, K. N., & Crews, F. T. 1999 Pharmacological treatment of alcohol dependence: A review of the evidence. Journal of the American Medical Association, 281, 1318-1325.
12. Hughes, J. C., & Cook, C. C. H. 1997 The efficacy of disulfiram: A review of outcome studies. Addiction, 92, 381-395.
13. Hunt, R. R. 2002 How effective are pharmacologic agents for alcoholism? Journal of Family Practice, 51(6), 577.
14. Johnson, J. A., & Roman, P. M. 2002 Predicting closure of private substance abuse treatment facilities. Journal of Behavioral Services & Research, 29, 115-125.
15. Kimberly, J. R., & Evanisko, M. J. 1981 Organizational innovation: The influence of individual, organizational, and contextual factors on hospital adoption of technological and administrative innovations. Academy of Management Journal, 24, 689-713.
16. Knudsen, H. K., Johnson, J. A., Roman, P. M., & Oser, C. B. 2003 Rural and urban similarities and differences in private substance abuse treatment centers. Journal of Psychoactive Drugs, 35, 511-518.
17. Knudsen, H. K., & Roman, P. M. 2004 Modeling the use of innovations in private treatment organizations: The role of absorptive capacity. Journal of Substance Abuse Treatment, 26, 353-361.
18. Kosten, T. R., George, T. P., & Kosten, T. A. 2002 Potential of dopamine agonists in drug addiction. Expert Opinion on Investigational Drugs, 11, 491-499.
19. Lamb, S., Greenlick, M. R., & McCarty, D. (Eds.) 1998 Bridging the gap between practice and research: Forging partnerships with community-based drug and alcohol treatment. Washington, DC: National Academy Press.
20. Lennox, R. D., & Mansfield, A. J. 2001 A latent variable model of evidence-based quality improvement for substance abuse treatment. The Journal of Behavioral Health Services & Research, 28, 164-176.
21. Litten, R. Z., & Allen, J. P. 1999 Medications for alcohol, illicit drug, and tobacco dependence: An update of research findings. Journal of Substance Abuse Treatment, 16, 105-112.
22. Magura, S., Schildhaus, S., Rosenblum, A., & Gastfriend, D. 2002 Substance user treatment program quality: Selected topics. Substance Use & Misuse, 37, 1185-1214.
23. Mark, T. L., Kranzler, H. R., & Song, X. 2003 Understanding US addiction physicians' low rate of naltrexone prescription. Drug and Alcohol Dependence, 71, 219-228.
24. Mark, T. L., Kranzler, H. R., Song, X., Bransberger, P., Poole, V. H., & Crosse, S. 2003 Physicians' opinions about medications to treat alcoholism. Addiction, 98, 617-626.
25. Mechanic, D. 1997 Muddling through elegantly: Finding the proper balance in rationing. Health Affairs, 16(5), 83-92.
26. Mechanic, D., & McAlpine, D. D. 1999 Mission unfulfilled: Potholes on the road to mental health parity. Health Affairs, 18(5), 7-21.
27. nd edition. Chevy Chase, MD: ASAM.
28. Menard, S. 1995 Applied logistic regression analysis. Thousand Oaks, CA: Sage.
29. Mulligan, D. H., McCarty, D., Potter, D., & Krakow, M. 1989 Counselors in public and private alcoholism and drug abuse treatment programs. Alcoholism Treatment Quarterly, 6(3/4), 75-89.
30. Read, J. P., Kahler, C. W., & Stevenson, J. F. 2001 Bridging the gap between alcoholism treatment research and practice: Identifying what works and why. Professional Psychiatry: Research and Practice, 32, 227-238.
31. th ed.). New York: Free Press.
32. Roman, P. M., & Johnson, J. A. 2002 Adoption and implementation of new technologies in substance abuse treatment. Journal of Substance Abuse Treatment, 22, 1-8.
33. Roman, P. M., Johnson, J. A., & Blum, T. C. 2000 The transformation of private alcohol problem treatment: Results from a national study. Advances in Medical Sociology, 7, 321-342.
34. Simpson, D. D. 2002 A conceptual framework for transferring research to practice. Journal of Substance Abuse Treatment, 22, 171-182.
35. Sloboda, Z., & Schildhaus, S. 2002 A discussion of the concept of technology transfer of research-based drug "abuse" prevention and treatment interventions. Substance Use & Misuse, 37, 1079-1087.
36. Stoffelmayr, B. E., Mavis, B. E., & Kasim, R. M. 1998 Substance abuse treatment staff: Recovery status and approaches to treatment. Journal of Drug Education, 28, 135-145.
37. Swift, R. M. 1999 Drug therapy for alcohol dependence. New England Journal of Medicine, 340, 1482-1490.
38. Taleff, M. J., & Swisher, J. D. 1997 The seven core functions of a Master's level alcohol and other drug counselor. Journal of Alcohol and Drug Education, 42(3), 1-17.
39. Thomas, C. P., Wallack, S. S., Lee, S., McCarty, D., & Swift, R. 2003 Research to practice: Adoption of naltrexone in alcoholism treatment. Journal of Substance Abuse Treatment, 24, 1-11.
40. White, W. L. 1998 Slaying the dragon: The history of addiction treatment and recovery in America. Bloomington, IL: Chestnut Health Systems.